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Two mutations in the a-synuclein gene (A30P and A53T) have been linked
to autosomal dominant early-onset Parkinson’s disease (PD). Both
mutations promote the formation of transient protofibrils (prefibrillar
oligomers), suggesting that protofibrils are linked to cytotoxicity. In
this work, the effect of these mutations on the structure of a-synuclein
oligomers was investigated using electron microscopy and digital image
processing. The PD-linked mutations (A30P and A53T) were observed to
affect both the morphology and the size distribution of a-synuclein proto-
fibrils (measured by analytical ultracentrifugation and scanning trans-
mission electron microscopy). The A30P variant was observed to
promote the formation of annular, pore-like protofibrils, whereas
A53T promotes formation of annular and tubular protofibrillar struc-
tures. Wild-type a-synuclein also formed annular protofibrils, but
only after extended incubation. The formation of pore-like oligomeric
structures may explain the membrane permeabilization activity of
a-synuclein protofibrils. These structures may contribute to the
pathogenesis of PD.
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Introduction
Parkinson’s disease (PD) is a neurodegenerative
movement disorder that is characterized by the
loss of dopaminergic neurons from the substantia
nigra, and the formation of fibrillar intraneuronal
inclusions (called Lewy bodies).1 – 3 Several lines of
evidence point towards a central role for the pro-
cess of a-synuclein fibrillization in the etiology of
PD. First, a-synuclein is the primary component
of Lewy bodies in all PD patients4. Second, two
different a-synuclein missense mutations (A30P
and A53T) are associated with rare, autosomal
dominant, early-onset PD5,6 and have been shown
to form fibrils. Third, transgenic mice and
Drosophila expressing human wild-type (WT)
a-synuclein or, in the flies, the mutants, are charac-
terized by a-synuclein inclusions that resemble
Lewy bodies.7,8 In both models, the formation of
these inclusions is correlated to the onset of disease
phenotype. Finally, the PD-linked mutations (A30P
and A53T), promote in vitro a-synuclein
oligomerization,9 – 12 suggesting that the process
of a-synuclein fibrillization may initiate neuro-
degeneration. a-Synuclein amyloid fibril formation
proceeds through a series of discrete oligomeric
intermediates, referred to as protofibrils, that
disappear upon fibril formation.13 Although both
PD-linked mutations accelerate the formation of
a-synuclein protofibrils, the A30P mutation was
shown to delay the formation of amyloid fibrils
relative to WT, suggesting that a-synuclein proto-
fibrils, rather than fibrils, may be the pathogenic
species.13 This hypothesis14 is supported by the
observation that a-synuclein deposits in the brains
of the “symptomatic” transgenic mice are
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non-fibrillar,7 and the fact that dopaminergic
neurons that contain Lewy bodies appear to be
healthier than neighboring neurons.2,15
Atomic force microscopy (AFM) analysis of
a-synuclein oligomerization demonstrates that
a-synuclein protofibrils exist in spherical, chain-
like and annular morphologies.11,13,16,17 Here, we
investigated the effect of the familial PD mutations
on the structural properties of a-synuclein proto-
fibrils. By extending the biophysical studies to
electron microscopy (EM), analytical ultracentrifu-
gation (AU) and scanning transmission electron
microscopy (STEM), we show that protofibrils of
defined molecular size distribution and mor-
phology are formed. In addition, we present a
detailed analysis of the morphological types of
protofibrils using EM and single-particle averaging
of negatively stained specimens. The potential
relevance of the observed structures to the mecha-
nism of pathogenesis of PD is discussed.
Results
a-Synuclein protofibrils are metastable and
can be separated and quantified by gel
filtration and sedimentation velocity
At concentrations of $200 mM in PBS (pH 7.4),
a-synuclein forms prefibrillar oligomeric species,
known as protofibrils, which disappear upon
formation of amyloid fibrils.9,11,13 To examine the
effect of a-synuclein mutations on the formation
of protofibrils, we determined the amount of proto-
fibrils formed by both the mouse and human
a-synuclein (WT), and the human PD-linked
mutants A30P and A53T by gel filtration (GF)
(,350 mM) using a Superdex 200 HR column. The
relative amount of protofibrils was determined by
calculating the area under the void peak using
the Millenium software (Waters, Milford, MA).
Figure 1(a) shows a typical GF chromatogram of
A53T a-synuclein. a-Synuclein eluted as three
peaks corresponding to protofibrillar oligomeric
species (20 minutes), dimer† (28 minutes), and
monomer (33 minutes). Protofibrils were observed
with the four protein variants. The relative
amounts of protofibrils formed under identical
solution conditions were as follows: mouse .
A53T .A30P . human WT a-synuclein (data not
shown). The amount of protofibrils formed never
exceeded 15% of the total protein in solution.
After reaching a critical concentration,13 proto-
fibrils suddenly disappeared, coincident with the
appearance of amyloid fibrils (as observed in the
EM). Analysis of a-synuclein protofibril fractions
by matrix-assisted laser desorption ionization
(MALDI) mass spectrometry revealed a single
molecular mass value identical with that of
full-length a-synuclein (Supplementary Material
Figure 1).
The homogeneity of the stock solutions analyzed
by GF was assessed by sedimentation velocity ana-
lytical ultracentrifugation (SVAU). Sedimentation
velocity studies revealed that a-synuclein
(200 mM) sedimented as two boundaries; a fast-
moving boundary corresponding to protofibrils,
and a slowly moving boundary corresponding to
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Figure 1. a-Synuclein forms protofibrils that can be resolved by GF and SVAU methods. (a) An analytical GF chro-
matogram of a-synuclein (A53T) stock solution (350 mM). a-Synuclein in 10 mM Tris–HCl (pH 7.4), 150 mM NaCl
was loaded onto a Superdex 200 HR 10/30 GF column, and elution of the protein was followed by measuring absor-
bance at 220 nm and at 254 nm. The arrows indicate the elution volumes of the standards (blue dextran 2000 (1), thyro-
globulin, 669 kDa (2); ferritin, 440 kDa (3); catalase, 232 kDa (4); aldolase, 158 kDa (5); albumin, 68 kDa (6);
chymotrypsinogen A, 25 kDa (7); and ribonuclease A, 13.7 kDa (8)). (b) Sedimentation velocity profiles of A53T stock
solution (200 mM). The fast-sedimenting boundary (arrow) corresponds to the sedimentation of A53T protofibrils,
whereas the slowly sedimenting boundary corresponds to the sedimentation of predominantly monomeric A53T.
† Analysis of this dimer by matrix-assisted laser
desorption/ionization (MALDI) mass spectrometry and
sedimentation velocity revealed an apparent mass of
28 kDa, consistent with a covalent dimer. Furthermore,
incubation of monomeric a-synuclein (37 8C) revealed a
steady increase in the void peak, but no dimer peak was
observed by GF. It is unknown what the dimer
represents, whether it is an artifact of bacterial
expression or normal cells may secrete dimeric forms.
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the monomer and dimer (Figure 1(b)). The amount
of protofibrils formed (on the basis of absorbance
values) corresponded to #10% of the total protein
in solution, consistent with GF chromatography
results. Furthermore, dilution and/or re-injection
of purified protofibril fractions onto the GF column
revealed only very small amounts of monomer,
even after ten days of incubation at 4 8C (data not
shown).
To estimate the molecular mass (Mr ) of a-synu-
clein protofibrils, the retention time on Superdex
200 was compared to those of other proteins with
sizes ranging from 13.7 kDa to 669 kDa (Figure
1(a)). The early void peak containing a-synuclein
protofibrils eluted slightly ahead of thyroglobulin
(669 kDa), whereas the middle fractions of the
peak eluted between the thyroglobulin and ferritin
(440 kDa) standards, suggesting an average Mr
for the protofibrils of greater than 600 kDa
(corresponding to .42 monomers). However,
a-synuclein monomer and dimer,1 identified by
SVAU analysis, eluted with an apparent Mr of
67 kDa (33 minutes) and 125 kDa (28 minutes),
suggesting a non-globular shape for both forms.
Accordingly, a non-globular conformation of
a-synuclein would result in an overestimation of
Mr for protofibrils.
AU of the heterogeneous protofibril fraction
reveals four subpopulations, the occupancy of
which is sensitive to the mutations
To estimate the size distribution of protofibrillar
structures and to characterize their morphology,
SVAU and EM analyses were performed. Proto-
fibrils of mouse, human WT, A30P, and A53T
(5 mg/ml) were fractionated and analyzed. The
sedimentation profiles were analyzed using the
time derivative method to yield the apparent
distribution of sedimentation coefficients, g(s p).
Figure 2 shows the distributions of sedimentation
coefficients obtained from experiments performed
on purified protofibrils of the four variants. The
prominent maximum corresponds to the sedimen-
tation coefficient of the major species in solution.
When compared to human a-synuclein variants,
mouse a-synuclein showed a broader distribution
of sedimenting species (10–70 S), suggesting that
Figure 2. The distribution of protofibrillar quaternary structures is dependent on the variant of a-synuclein. The
apparent distributions of sedimentation coefficient (g(s p)) for (a) mouse WT, (b) human WT, (c) A53T and (d) A30P
a-synuclein were obtained using time derivative analysis of the SVAU data for each protein at 300 mM. The black line
reflects the best least-squares fit of the data (O) to a three-species model using a Gaussian function.
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this protein formed oligomers of greater molecular
mass. In addition to the 17 S population (green
line) being the major species in solution, the g(s p)
plot revealed two other sub-populations of proto-
fibrils with average sedimentation coefficients of
28 S (pink) and 42 S (orange) (Figure 2(a)). Human
WT oligomers showed a narrower distribution
of species, the major one having a sedimentation
coefficient of 13 S (red line, Figure 2(b)). Like
mouse a-synuclein, the A53T protofibrils were
dominated by the 17 S species (Figure 2(c)). In
contrast, the A30P variant protofibrils exhibited
a distribution similar to that of human WT a-synu-
clein (Figure 2(d)). In negatively stained EM
samples, the protofibrils showed a heterogeneous
distribution of morphologies. In addition to the
spherical protofibrils, significant amounts of novel
annular and tubular protofibrils of identical
diameters (,11(^1) nm) were observed in the
case of the PD-linked variants sample (see below).
Although the WT oligomers showed a sedimen-
tation coefficient distribution similar to that of the
A30P variant (the major species having a sedimen-
tation coefficient of 13 S), examination by EM
revealed the absence of annular and tubular
protofibrils.
Over time, annular protofibrils form tubes,
then ultimately fibrils
To investigate whether the annular and tubular
protofibrils represent different stages of assembly
into amyloid fibrils, we carried out time-dependent
EM and SVAU studies on WT, A53T, and A30P
a-synuclein protofibrils. Although the protofibrils
retained the annular and tubular morphologies
even after incubation for one to two months at
4 8C, over time, their size distribution shifted
towards higher Mr protofibrillar structures (Figure
3(a)). For example, SVAU experiments on purified
A53T protofibrils after 12 days of incubation (4 8C)
demonstrated a significant increase in the amount
of the 17 S species in solution, suggesting a slow
conversion between the species in solution
(compare Figure 3(b) to Figure 2(c)). In contrast,
the apparent sedimentation coefficient distribution
Figure 3. Time-dependent EM and SVAU reveals a shift in molecular mass distribution and conversion of annular
particles into tubular structures. (a) Electron micrograph area of negatively stained A53T protofibrils incubated at
4 8C for one month. (b) The apparent distribution of sedimentation coefficients of purified A53T protofibrils after incu-
bation at 4 8C for 12 days. (c) Typical electron micrograph area taken from a negatively stained A30P fibril formed from
A30P protofibrils in the presence of monomeric a-synuclein. (d) Projection average of an A30P fibril calculated from
549 cut-out fibril crossovers.
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g(s p) of WT and A30P remained virtually
unchanged over this time (data not shown).
Negatively stained EM samples of A53T proto-
fibrils incubated for two weeks (4 8C) also showed
the presence of long tubular structures, which
were absent at early time-points (Figure 3(a)). The
observation of longer tubes is consistent with the
shift in A53T molecular size distribution observed
by SVAU. After four weeks of incubation at 4 8C,
WT a-synuclein was observed to form annular
protofibrils (Supplementary Material Figure 2),
whereas spherical protofibrils ranging in diameter
from 13 nm to 17 nm were observed for A30P
after longer incubations. In all cases, fibril for-
mation was not detected in the protofibrillar
samples (even after ten days of incubation at
37 8C). In contrast, incubation of a-synuclein proto-
fibrils in the presence of excess monomeric a-synu-
clein resulted in fibril formation and protofibril
consumption within a few days at 37 8C. The fibrils
exhibited a helical twist and had a diameter similar
to that of the annular and tubular protofibrils
(11 nm on average) (Figure 3(c) and (d)). The
annular and tubular protofibrils exhibited resist-
ance to proteinase K (PK), suggesting that they
represent ordered intermediates on the fibrillo-
genesis pathway. After two hours of digestion
with PK, several low Mr proteolytic-resistant
fragments could be seen, one of which persisted
even after four hours of treatment (Supplementary
Material Figure 3). Similar fragments have been
observed for a-synuclein fibrils after digestion
with PK.18 These fragments were mapped to the
hydrophobic region of a-synuclein known as the
non-amyloid component (NAC) (residues 61–95),
thought to be critical for a-synuclein fibrillization.18
Fractionation of the protofibrillar void peak
results in partial separation of a-synuclein
protofibrillar morphologies
The sedimentation coefficient distribution plots
of WT, A53T and A30P a-synuclein revealed the
presence of two major populations of protofibrils
with an average sedimentation coefficient of 13 S
and 17 S (Figure 2), suggesting common proto-
fibrillar intermediates on the pathway to the fibril.
To gain further insight into the structural features
of these protofibrillar intermediates, we sought to
further purify these species by fractionation of the
Figure 4. Relative separation of a-synuclein protofibrillar species by fractionation of the void protofibril peak.
(a) Gel-filtration chromatogram illustrating how the void peak was divided into three fractions (early, middle, and
late). The apparent distribution of sedimentation coefficients (g(s p)) for the purified (b) early, (c) middle, and (d) late
fractions of the void peak of A53T.
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a-synuclein protofibril peak. Three fractions corre-
sponding to the early, middle and late fractions of
the void peak were collected using TSK-Gel G4000
SWxl GF column (Figure 4(a)). The fractions were
concentrated to 15–20 mM prior to analysis.
The sedimentation data again demonstrated the
presence of three populations of protofibrils, with
average sedimentation coefficients of 13(^1),
17(^1), and 25–30(^1) S (Figure 4(b)–(d)).
Assuming a globular structure, these sedimen-
tation coefficients correspond to an average Mr
of 308 kDa (n ¼ 21, n ¼ number of a-synuclein
monomers), 368 kDa (n ¼ 26), and 539 kDa
(n ¼ 38), respectively (see Materials and Methods).
The early (fastest eluting) A53T fraction showed
the 17 S as the major species followed by the 13 S
and 30 S species (Figure 4(b)). The amount of the
13 S species increased in the late-eluting fraction
(late, see Figure 4(a)), becoming the predominant
species (Figure 4(c) and (d)). In the case of the
A30P variant, the middle fraction consisted pre-
dominantly of the 13 S species, consistent with the
narrow distribution observed by SVAU (Figure
2(d)). It is not clear whether the 13 S species corre-
sponds to dissociated subunits of the higher
species (17 S, 24 S or 40 S) or represents the
first-formed protofibrillar species.
Quantitative analysis of a-synuclein proto-
fibrillar subpopulations by STEM revealed a
mass distribution consistent with that
predicted by AUSV
STEM allows the determination of Mr of indi-
vidual particles, independent of the shape or
hydrodynamic properties of the particles. To corre-
late the Mr of A53T and A30P particles to a particu-
lar morphology, the various void peak fractions
were analyzed by STEM. Protofibrils of various
sizes could be distinguished on the images, and
were selected automatically using a set of models
of overlapping sizes (using the PCmass software),
which located all isolated particles in each image.
The predominant particle shapes observed
were: (a) relatively amorphous round particles
13–15 nm in diameter; and (b) relatively compact
particles roughly 9 nm in diameter, frequently
with a central depression. The high brightness and
central depression are consistent with a cylinder
viewed end-on. Side-view tubes were observed
Figure 5. Quantitative STEM analysis of a-synuclein particles reveals a mass distribution consistent with that pre-
dicted by SVAU. (a) Electron micrograph of unstained/freeze-dried A53T-synuclein particles recorded by STEM.
Light regions represent areas of high-mass density and dark regions represent areas of low mass density. (b) STEM
micrographs of vanadate-stained protofibrillar fraction of A53T revealing annular and tubular structures. TMV (diam-
eter 1.8 nm) was included in each specimen as an internal standard. (c) Histograms of molecular mass measurements
of A53T and A30P particles from early, middle, and late protofibrillar void fractions purified by GF.
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frequently in the A53T void specimens (Figure 5(a)
and (b)). Mass measurements of all detected par-
ticles demonstrated that partial separation of the
protofibril populations was achieved by fraction-
ation of the protofibril peak (Figure 5(c)). STEM
analyses confirmed that A53T protofibrils are
more heterogeneous and exhibit a wider
molecular mass distribution relative to A30P
(Figure 5(c)). An unfractionated sample of A53T
protofibrils gave a mass distribution with a broad
peak due to particles ranging in mass from
180 kDa to 950 kDa. Given a molecular mass of
14.4 kDa for the monomeric protein, this range
would correspond to particles comprising 12–66
monomers. Interestingly, the late fractions yielded
less heterogeneous protofibrils in the range of
,350(^50) kDa (24(^3) monomers), consistent
with those predicted by SVAU (Figure 4(d)). For
both A53T and A30P, there were very few particles
in the 100 kDa range, consistent with the absence
of any significant amount of sedimenting species
with an s value below 10 S.
Differences in protofibril size distributions
correspond to differences in
protofibril morphology
Differences in the distribution of species
detected by AU correspond to differences in proto-
fibril morphology as examined by EM. For
example, the early fraction of A53T contained
predominantly large spherical and tubular species
with an average diameter of 24 nm and 19 nm,
respectively (Figure 6(a)). Occasionally, annular
protofibrils with an average diameter of 11 nm
could be seen in this fraction (Figure 6(a)). The
amount of annular protofibrils increased signifi-
cantly in the fraction corresponding to the middle
of the A53T protofibril peak, whereas the majority
of the species in the late fraction were 10–12 nm
annular protofibrils (Figure 6(a)). The late fraction
contained a significant amount of tubular species,
which had an average diameter of 11 nm and an
average length of 24 nm. The far-UV CD spectrum
was consistent with a high content of b-sheet for
the annular and tubular protofibrils.19 The facts
that the major protofibrillar species in this fraction
is the 13 S species, and that the diameters of the
annular and tubular protofibrils are very similar,
suggest that the two morphologies may reflect top
and side-views of the same hollow cylindrical
protofibril structure. Alternatively, the annular
species may represent the 13 S species (308 kDa),
whereas the tubular structures may correspond to
the 17 S species (368 kDa using equation (1), see
Materials and Methods). For A30P, significant
amounts of annular protofibrils were observed
in both the early and middle fractions, but the
middle fraction appeared to be more homogeneous
(Figure 6(b)). The presence of spherical protofibrils
was prominent in the late fraction of A30P
(Figure 6(b)).
Figure 6. (a) Electron micrograph areas of negatively stained samples obtained from the fractionation of the A53T
void peak. Far-UV CD spectrum of the late fraction demonstrating a high content of b-sheet for the A53T fraction
(late) rich in annular protofibrils. (b) Electron micrograph areas of negatively stained samples obtained from the
fractionation of the A30P void peak revealing annular and spherical protofibrils. The scale bars represent 50 nm.
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Single-particle averaging reveals a collection
of distinct, yet related annular, helical, and
tubular protofibrils
To gain further insight into the structural
features of a-synuclein protofibrils, we analyzed
protofibrillar fractions of A30P and A53T by
negative stain EM and single-particle averaging.
Electron micrographs of the late and middle frac-
tions of the void peak for A53T and A30P showed
annular and tubular structures with a relatively
homogeneous size distribution, and were therefore
chosen for further image processing. Representa-
tive images of negatively stained samples of A53T
and A30P are shown in Figure 7(a) and (c). A total
of 5000–6000 particles for each were selected from
31 images of A53T (late fraction) and from 16
images of A30P (middle fraction). Multivariate
statistical analysis was then used to divide the
data sets of 5815 particles for A53T and 5040
particles for A30P into 100 output classes
(Supplementary Material Figure 4(a) and (b)).
These 100 classes fell into four major groups of
structures. A gallery with representative class
averages obtained from images of A53T (late
fraction) is shown in Figure 7(b), illustrating
the four major groups of protofibril structures.
The first group consisted of what appears to be
incomplete rings, where one end of the protofibril
seemed to lie above the other end, suggesting a
Figure 7. Electron microscopy and averaging of protofibrils reveal annular and tubular quaternary structures. (a)
Negative stain EM of A53T protofibrils from the late fraction of the GF purified void peak. (b) A gallery of representa-
tive class averages calculated from a total of ,6000 A53T particles. (c) Negative stain EM of A30P protofibrils from the
right fraction of the GF purified void peak. (d) A gallery of class averages calculated from a total of ,5000 A30P par-
ticles. The size of each box corresponds to 40.5 nm.
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helical symmetry for these structures (Figure 7(b),
1–3). The second group showed annular structures
having an average diameter of approximately
10–12 nm and a central stain-filled cavity that is
2 nm in diameter (Figure 7(b), 4–6). The third
group showed rectangular particles with a mean
diameter of 12 nm and varying length of
11–20 nm (Figure 7(b), 7–9). The presence of
rectangular particles with similar diameter but
closely spaced lengths is likely to reflect different
stages of protofibrillar growth. The similar
diameter observed for the annular and rectangular
particles suggests that the two morphologies
represent two different views (top and side-view)
of the same species. Alternatively, the rectangular
particles may form by end-to-end stacking of
annular particles. The fourth group showed large
aggregates, some of which appeared to be formed
by two rectangular particles joint at a 908 angle
(Figure 7(b), 10–12).
Figure 7(c) shows a typical area of an electron
micrograph taken from negatively stained A30P
(middle fraction), revealing the annular structures
to be the predominant species in this sample.
A gallery of representative averages of A30P
(middle fraction) is shown in Figure 7(d), reflecting
at least three groups of protofibrillar structures.
The first group contained chain-like structures
that formed rings with slightly displaced ends,
which are likely to represent the precursors for the
helical fibrils (Figure 7(d), 1–3). The second group
represents the majority of the structures for A30P
that consist of annular structures approximately
10–12 nm in diameter with an inner core diameter
of 2–3 nm (Figure 7(d), 4–6). Rings of smaller
diameter (,8 nm) were present in significant
amounts. The third group contains large spherical
particles with an average diameter of 24 nm
(Figure 7(d), 7–9). Unlike A53T, tubular particles
were not observed for A30P. The possibility that
the tubular particles of A30P did not adsorb to
the EM grids is unlikely, since they were clearly
present in samples of A53T. These results are
consistent with the narrow molecular mass
distribution predicted by SVAU and the reduced
assembly rate of A30P relative to A53T.
Discussion
The two PD-linked mutations A30P and A53T
promote the formation of a-synuclein protofibrils,
suggesting a causal role for protofibril formation
in PD.11,13,16 These protofibrillar intermediates are
structurally heterogeneous. To identify a patho-
genic protofibrillar species and to understand the
relationship between their morphologies and
cytotoxicity requires a detailed characterization of
the protofibrils. Here, we apply negative stain EM
and single-particle averaging to characterize the
formation and structural heterogeneity of a-synu-
clein protofibrils by WT a-synuclein and the
PD-linked variants A30P and A53T. To facilitate
the structural characterization of protofibrils, GF,
SVAU, and STEM were utilized in parallel with
EM to obtain protofibrillar preparations of defined
molecular size distribution and morphology.
Several important themes have emerged from this
work.
Parkinson’s disease-linked mutations promote
the formation and/or stabilize annular
a-synuclein protofibrils
Despite the heterogeneity of the protofibrils,
SVAU analysis revealed that all three a-synuclein
variants populated predominantly three major
classes, with sedimentation coefficients of 13 S,
17 S, and 25 S, suggesting common fibrillization
intermediates. It is important to emphasize that
neither the 13 S nor 17 S species corresponds to a
single sedimenting protofibrillar species, but rather
to a narrow distribution of protofibrils with an
average sedimentation coefficient of 13 S or 17 S.
The A53T mutation, in addition to promoting
protofibril formation,13 shifted the molecular size
distribution towards higher Mr protofibrils relative
to the WT and A30P variants. These three classes
of protofibrils were purified partially by GF.
Characterization of these fractions by EM, image
processing and STEM revealed novel annular and
tubular protofibrillar structures, in addition to the
previously reported spherical and chain-like mor-
phologies. The annular protofibrils had an average
diameter of 11(^1) nm, and an inner diameter of
2–3 nm; the tubular protofibrils showed similar
diameter (10–12 nm), and varied in length from
12 nm to 24 nm.
Molecular masses estimated from the sedimen-
tation coefficient and obtained from STEM analysis
suggest that the smallest oligomeric species has
Mr , 140 kDa, pointing to a decamer as the
smallest detectable metastable oligomer. Both
techniques also suggest an average Mr of
,350(^50) kDa for the annular protofibrils. Each
of the techniques used for the determination of Mr
has its own limitations. GF depends on the shape
of the protein and its interaction with the column
matrix, whereas estimates on the basis of the sedi-
mentation coefficient values assume a globular
structure for all protofibrils which is not the case
in all samples. STEM measurements are on the
basis of the assumption that all protofibrillar
species were equally adsorbed on the surface of
the EM grid. We have addressed these issues by
comparing the results from three complementary
approaches (AU, STEM, and GF), allowing the
size of the protofibrils to be estimated with a good
degree of accuracy.
EM images showed that the protofibrils formed
by both A53T and A30P variants populated three
or four morphological classes, the most common
type being the annular protofibrils. Although both
variants rapidly formed annular structures, tubular
protofibrils were observed only for A53T. In con-
trast to the PD-linked variants, WT a-synuclein
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formed annular protofibrils only after incubation
for several (six to eight) weeks. A wide range of
bacterial and insect toxins utilize a-helices to
perturb or penetrate membranes, whereas other
toxins, such as aerolysin and staphylococcal
a-hemolysin, form b-barrels that span the
membrane.20,21 Formation of b-barrels lowers the
energetic barrier for the insertion of non-hydro-
gen-bonded b-strands into the membranes.
Generally, these b-barrels are composed of 8–22
b-strands (ten to 13 residues) and have an average
diameter of 1.5–3.5 nm.21,22 In a-hemolysin (hepta-
mer), each monomer contributes an amphipathic
hairpin to a 14-stranded b-barrel.23 a-Synuclein
annular protofibrils have secondary (b-sheet) and
quaternary (2.5 nm pore-like annular and tubular
structures) structural features in common with
aerolysin and staphylococcal a-hemolysin. The
data presented here do not prove that a-synuclein
self-assembles to a b-barrel pore. However, on the
basis of our observations, we speculate that a
b-strand solvent-accessible pore with a diameter
of 2–3 nm could be formed by b-barrel structures
composed of 20–24 a-synuclein monomers.
The different protofibrillar morphologies seem to
be related
A relationship between spherical and annular
protofibrils has been proposed on the basis of
AFM studies of a-synuclein.17 The studies above
do not address the pathway, but the intermediates
may represent protofibrils at different assembly
stages in a linear or parallel path to the stable
fibrils. Annular and tubular protofibrils have
similar diameters, suggesting that the two struc-
tures represent the two different views (top and
side-view) of the same protofibrillar species, with
their different appearance in electron micrographs
merely reflecting different interactions with
the surface of the carbon-coated copper grid.
Incubation of samples rich in annular protofibrils
at 4 8C (four to eight weeks) revealed images with
an increasing population of longer tubes, a result
that could also be caused by an increasing propen-
sity of tubes to adsorb with their sides to the grid
as they grow in length. This transition coincides
with a shift in the molecular size distribution of
the protofibrils from 13 S (predominately annular)
to 17(^1) S (predominately tubular).
a-Synuclein protofibrils are precursors to fibrils,
but the mechanism of conversion remains unknown
In the presence of monomeric a-synuclein,
annular and tubular protofibrils were consumed
upon fibril formation, consistent with their being
transient assembly intermediates on the fibril for-
mation pathway. The fibrils exhibited a helical
twist and have a diameter that is similar to that of
the annular and tubular protofibrils (ca 11 nm).
Although a model in which the amyloid fibril is a
hollow cylinder or tube has been proposed on the
basis of the X-ray fiber diffraction data,24,25,47 the
resolution of the EM data presented here does not
allow conclusions to be drawn about whether this
is the case for a-synuclein fibrils. The mechanism
by which annular and tubular protofibrils convert
to fibrils is under investigation in our laboratory.
Both annular and tubular protofibrils, like the
fibrils, showed b-sheet secondary structure and
resistance to proteolysis by PK.18 Together, these
results indicate that the inter-monomer interactions
in the protofibril are similar to those of the fibril,
suggesting a common core structure.
The annular, pore-like protofibrils may be
responsible for in vitro vesicle
permeabilization and, possibly, PD
Although a toxic role for protofibrils has been
suggested in several neurodegenerative diseases,
the mechanism of its toxicity has not been
elucidated.14,26 – 28 Our own studies have demon-
strated that protofibrillar a-synuclein exhibits tight
binding to phosphatidylglycerol (PG) vesicles via a
b-sheet-rich oligomeric structure, and binding
results in permeabilization. Monomeric and
fibrillar a-synuclein showed little binding and
no permeabilization activity.19 Size-dependent
permeabilization studies revealed that small
(calcium, dopamine and fura-2) molecules were
released from the vesicles by a-synuclein proto-
fibrils, whereas large molecules such as FITC-
dextran (4400, 26 A˚ in diameter) were imper-
meable.29 These results suggest that vesicle
permeabilization may occur largely as a result of a
specific membrane perturbation, likely via the for-
mation of a pore that is at least 2.5 nm in diameter,
consistent with the diameter of the annular and
tubular protofibrils described here. Addition of
protofibrillar a-synuclein (WT or A53T) to brain-
derived vesicle (BDV) fractions allowed the obser-
vation of pore-like structures,17 which resemble, in
overall morphology and dimension, membrane-
spanning pores that are formed by protein toxins
(e.g. hemolysin, latrotoxin, and aerolysin).20,30 In
preliminary experiments, the annular and tubular
protofibril fractions were observed to permeabilize
synthetic vesicles (M. Volles & H.A.L., unpublished
results), providing further support for the con-
clusion that permeabilization by a-synuclein proto-
fibrils occurs via a localized pore-like mechanism.29
Several amyloidogenic proteins associated with
different neurodegenerative diseases (Alzheimer’s
disease, Huntington disease, and prion diseases)
form ion-permeable pores at cytotoxic concen-
trations, strongly suggesting that membrane dis-
ruption, via pore formation, may be a general
mechanism of cytotoxicity for neurodegenerative
diseases.19,29,31 – 36
We propose that an increase in the levels of
protofibrils or the selective population of particular
protofibrillar morphologies may initiate early PD.
Several factors are likely to modulate the formation
and stability of a-synuclein protofibrils in vivo,
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including mutations, post-translational modifi-
cations and interactions with related proteins. For
example, the interaction of a-synuclein with dopa-
mine promotes the formation of protofibrils.37
Finally, a significant implication of our findings is
that there may be a close relationship between
formation of pore-like protofibrils, membrane
permeabilization and the mechanism of neuro-
toxicity in PD.
Materials and Methods
Preparation and purification of
a-synuclein protofibrils
Recombinant a-synuclein was expressed and purified
as described.13 To prepare a-synuclein protofibrils,
lyophilized a-synuclein variants were dissolved in phos-
phate-buffered saline (PBS) (0.01 M sodium phosphate
buffer (pH 7.4), 150 mM NaCl) to obtain concentrations
of 300–700 mM. The stock solutions were incubated on
ice for 30–60 minutes before being centrifuged at
16,000g for five minutes, and filtered through a 0.22 mm
nylon spin filter (Costar) to remove any insoluble par-
ticles. The filtrates were loaded (100 ml/injection) onto a
Superdex 200 HR (Amersham Pharmacia) GF column
equilibrated with protein buffer (10 mM Tris–HCl (pH
7.4), 150 mM NaCl), and protein was eluted at a flow-
rate of 0.5 ml/minute. Fractions of 0.5 ml were collected
using a Waters fraction collector (model II). Fractions
corresponding to the void peak were either combined or
split into three fractions (early, middle, and late) and
used for biophysical studies. Purified protofibril
fractions were stored at 4 8C. Samples for EM and SVAU
were prepared within three days unless indicated
otherwise.
Molecular mass determination using GF
a-Synuclein samples (300 mM) in volumes of 100–
150 ml were injected onto the column (Superdex 200 or
Tsk-Gel G4000 SWxl) and eluted at a flow-rate of
0.5 ml/minute. The retention time for the protein was
monitored by measuring the absorbance at 220 nm,
254 nm, and 280 nm. The Mr value for the a-synuclein
samples was estimated using the following standards:
blue dextran, 2000 kDa; thyroglobulin, 669 kDa; ferritin,
440 kDa; catalase, 232 kDa; aldolase, 158 kDa; albumin,
68 kDa; chymotrypsinogen A, 25 kDa; and ribonuclease
A, 13.7 kDa.
Circular dichroism spectroscopy
Far-UV CD spectra of purified protofibrils in protein
buffer (10 mM Tris–HCl (pH 7.4), 150 mM NaCl) were
collected at 25 8C using an Aviv 62A DS spectro-
photometer and a 0.1 cm cuvette. Data were acquired at
a step size of 0.2 nm with an averaging time of three
seconds. For each sample, the mean residue ellipticity
was reported as an average of three scans.38
Electron microscopy and image processing
Purified protofibril fractions of A53T and A30P a-
synuclein were diluted sixfold with protein buffer prior
to adsorption to glow-discharged, carbon-coated copper
grids. Grids were washed with four drops of buffer and
stained with two drops of freshly prepared 0.75% (w/v)
uranyl formate (Pfaltz & Bauer, Waterbury, CT 06708).
Specimens were inspected with a Philips Tecnai 12 elec-
tron microscope operated at 120 kV and images were
taken at a nominal magnification of 52,000 £ using low-
dose procedures. For image processing, 31 images of
A53T (late fraction of the void peak) and 16 images of
A30P (middle fraction of the void peak) were digitized
with a Zeiss SCAI scanner using a pixel size of 4.04 A˚ at
the specimen level. From the digitized images, 5815
(A53T), and 5040 (A30P) particles were selected for
further computational processing using the SPIDER
image processing package.39 The 5000–6000 particle
images were subjected to ten rounds of alignment and
classification specifying 100 output classes. In the case
of a-synuclein fibrils, 1172 fibril crossovers were cut out
from 30 images, from which 549 were included in the
final projection average.
Sedimentation velocity analytical
ultracentrifugation (SVAU)
Sedimentation velocity data were collected in a
temperature-controlled Beckman XL-A. A double-sector
cell, equipped with a 12 mm Epon centerpiece and
quartz windows was loaded with 400–420 ml of protein
sample. Data were collected at rotor speeds of 3000–
60,000 rpm in continuous mode at 25 8C, with a step
size of 0.005 cm and an average of three scans per point.
Purified void fractions isolated by GF and stored at 4 8C
were incubated at room temperature for one to two
hours prior to the SVAU experiments at 25 8C.
Analysis of the sedimentation velocity data
For samples containing a-synuclein monomer or a
monomer–dimer mixture, the absorbance data were fit
using the direct boundary fitting approach using the
Svedberg analysis program developed by Philo as
described.40 For heterogeneous samples containing
multiple species, the sedimentation velocity absorbance
profiles were analyzed to obtain the apparent distri-
bution of sedimentation coefficients g(s p) for all the
quaternary structures in solution using the DCDT soft-
ware provided by Philo.41,42 The Mr value of globular
proteins can be estimated from their sedimentation coef-
ficient using equation (1), where y¯ is the partial specific
volume of a-synuclein (ml/g), and r is the density of
the solvent (in g/ml).43 The partial specific volume of
a-synuclein (0.734 cm3/g) was estimated on the basis of
the partial specific volumes of the component amino
acid residues, whereas the density of the buffers was
calculated using polynomial equations and tables of
coefficients solution:44,45
ðMrÞ
2
3 ¼ 100sy
1
3
ð12 yrÞ
ð1Þ
Scanning transmission electron microscopy (STEM)
Protofibril fractions of A53T and A30P were analyzed
by STEM at the Brookhaven National Laboratory using
unstained, freeze-dried samples. Protein samples
(10–20 mM) were applied to a thin carbon film supported
by a thick holey film on titanium grids, wicked to a thin
layer, frozen rapidly to avoid ice crystal formation and
freeze-dried overnight. The freeze-dried, unstained
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specimens were transferred to the STEM under vacuum
and examined at 2150 8C and 40 kV using the annular
dark-field detector mode. Tobacco mosaic virus (TMV)
was included in all specimens to monitor preparation
quality. Digital images of 512 £ 512 pixels with 1 nm
spacing were recorded at an average dose of
300–1000 e/nm2. Processing of the STEM data for mass
determination was carried out using the PCMass soft-
ware package as described.46
Digestion with proteinase K (PK)
A 1 ml aliquot of 150 mg/ml of proteinase K (Sigma)
was added to 35 ml of purified A53T (late fraction) proto-
fibrils. Before addition of PK, 10 ml of a protofibril
solution was boiled in SDS running buffer and incubated
at room temperature for four hours to serve as a control
for the untreated sample. At different time-points, an
aliquot of 10 ml was taken for analysis. Each aliquot was
quenched by addition of SDS sample buffer and boiled
for ten minutes before being resolved on an SDS/
10–20% (w/v) polyacrylamide gel (tricine (N-[Tris-
hydroxymethylo-methyl]-glycine) buffer). The proteins
were detected by silver staining.
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Note added in proof: After submission of this manuscript, we learned that we can obtain a better separation
of A53T a-synuclein protofibrils by using a Superose 6 GF column (10/30 HR Amersham Pharmacia)
instead of a Superdex 200 (10/30 HR Amersham Pharmacia). Usage of this column yielded a more
homogeneous protofibri distribution, especially for the lowest Mr fraction (Late) as was verified by EM
(Supplementary Figure 5) and STEM (Supplementary Figure 6).
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